Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Clinical Genetics · Hypermobile Ehlers-Danlos Syndrome

How Do hEDS, Classical EDS, vEDS, Marfan, and LDS Differ?

At a Glance

hEDS mainly causes generalized joint hypermobility, pain, and instability and usually does not cause severe arterial or organ fragility. Classical and vascular EDS, Marfan syndrome, and Loeys-Dietz syndrome have distinct skin, eye, skeletal, genetic, and artery-related risks.

In this answer

4 sections

01

Characteristic Patterns

02

At-A-Glance Comparison

03

Areas of Overlap

04

When to Seek Specialty Care

If you have hypermobile Ehlers-Danlos syndrome (hEDS) or suspect you might, it is normal to worry about more dangerous vascular conditions. While these inherited connective-tissue disorders share features like flexible joints, their risks and testing are very different. Most people with hEDS do not have severe arterial or organ fragility [1]. In contrast, classical EDS features extreme skin fragility, while vascular EDS, Marfan syndrome, and Loeys-Dietz syndrome carry different, specific risks for arterial aneurysms (abnormal widening), dissections (tears within the artery wall), or organ ruptures (full-thickness failure with bleeding) [2][3][4]. These risks vary by person and condition, and specialized surveillance and treatment can substantially improve safety [5].

Because these conditions can look similar, diagnosis requires a complete medical evaluation [6].

Characteristic Patterns

Each condition has a distinct clinical pattern, though no single symptom is diagnostic on its own:

  • Hypermobile EDS (hEDS): Centers on generalized joint hypermobility, musculoskeletal pain, and often joint instability or dislocations [6][7]. While mild skin stretchiness is common, it is not required for diagnosis [8]. hEDS can also cause significant non-vascular problems like chronic pain and fatigue [9]. hEDS is diagnosed using formal clinical criteria that require excluding other disorders, and its genetic cause remains unknown [6][10]. People with similar symptoms who do not meet all hEDS criteria may be diagnosed with hypermobility spectrum disorder (HSD) [11].
  • Classical EDS (cEDS): The defining feature is extreme skin fragility and stretchiness. People with cEDS easily get wounds that heal into wide, sunken scars called atrophic scars [2]. While joint hypermobility is present, the severe skin tearing sets cEDS apart [12]. It is usually associated with the COL5A1 or COL5A2 genes [13].
  • Vascular EDS (vEDS): Marked by life-threatening fragility of arteries and hollow organs (organs like the intestine or uterus that can tear) [3]. Patients face risks of spontaneous arterial rupture, bowel tearing, or rupture of the gravid uterus during pregnancy [3][14]. Arteries can tear even when they are not significantly enlarged [15]. It is caused by mutations in the COL3A1 gene [16].
  • Marfan Syndrome: Combines cardiovascular, skeletal, and eye features. It frequently causes enlargement or tearing of the aortic root (the start of the main artery leaving the heart) [4]. Skeletal clues include unusually long fingers (arachnodactyly), chest wall deformities, and scoliosis [17]. A key eye finding is ectopia lentis (dislocation of the lens of the eye), though not everyone with Marfan has it [4]. It is linked to the FBN1 gene [4].
  • Loeys-Dietz Syndrome (LDS): Features widespread arterial aneurysms and tortuosity (twisting of the arteries) throughout the body [4]. In some individuals, arterial complications can develop at smaller dimensions than in Marfan syndrome [18]. Characteristic clinical clues include a cleft palate, a bifid uvula (a split in the tissue hanging at the back of the throat), and widely spaced eyes, though these are not present in every patient [4]. It is tied to genetic mutations in the TGF-beta pathway [4].

At-A-Glance Comparison

Condition Key Clinical Clues Primary Vascular/Organ Concern Gene Focus
hEDS Joint hypermobility, pain, instability Generally low; severe vascular events are not typical Diagnosed clinically; no established gene
cEDS Severe skin fragility, atrophic scars Usually low; rare arterial events reported COL5A1, COL5A2
vEDS Easy bruising, thin skin, characteristic facial features Arterial, bowel, or uterine rupture COL3A1
Marfan Long limbs, chest deformities, dislocated eye lens Aortic root aneurysm and dissection FBN1
LDS Split uvula, widely spaced eyes, twisting arteries Widespread arterial aneurysms and tortuosity TGF-beta pathway (TGFBR1/2, etc.)

(Note: No single feature is diagnostic by itself. Overlap is common.)

Areas of Overlap

It is easy to get scared reading about these conditions because some symptoms overlap:

  • Skeletal findings: Scoliosis, chest deformities, and flat feet can occur in Marfan, LDS, and EDS [17][4].
  • Bone fragility: Reduced bone mineral density and an increased risk of fractures can happen in several of these conditions, though testing and treatment require individual assessment [19][20].
  • Mild vascular issues: Mild aortic root dilation (widening) has been reported in some patients with hEDS and cEDS [1][21]. This does not by itself establish a diagnosis of a vascular syndrome, but follow-up imaging should be guided by your specific measurements, age, and family history [1].

When to Seek Specialty Care

You should ask your doctor for a referral to a clinical geneticist, genetic counselor, or specialized cardiologist if you have “red flags,” such as:

  • A strong family history of early or unexplained sudden death, aortic aneurysms, or organ ruptures [22][23]. (Note that a lack of family history does not rule out these conditions, as new genetic mutations can occur [23]).
  • Personal history of unexplained bowel or arterial tearing [9].
  • Distinct physical features like a dislocated eye lens, severe skin tearing from minor cuts, or a split uvula [4][2].
  • Planning a pregnancy, particularly if you have or suspect vEDS, Marfan, or LDS, as you will need multi-specialty guidance before conception [3].

If a vascular syndrome is suspected, a connective-tissue genetic panel may be ordered [24]. However, testing is complex: a negative result does not rule out every connective tissue disorder, and a “variant of uncertain significance” is not a diagnosis [25]. Urgent medical management should not wait for genetic test results [26].

When to Go to the Emergency Room

If you have or suspect you might have vEDS, Marfan syndrome, or Loeys-Dietz syndrome, do not wait for a routine appointment if you experience serious symptoms. Seek immediate emergency evaluation for:

  • Sudden, severe chest, back, or abdominal pain
  • Fainting, collapse, or new stroke-like symptoms
  • Sudden severe shortness of breath
  • Major unexplained bleeding or internal bleeding signs
  • Acute abdominal pain or bleeding during pregnancy

Reassurance for hEDS: Ordinary, chronic musculoskeletal pain from hEDS does not mean you are having a vascular emergency.

Common questions in this guide

What is the main difference between hEDS and vascular EDS?
hEDS is mainly associated with generalized joint hypermobility, musculoskeletal pain, and joint instability, and severe arterial or organ events are not typical. Vascular EDS is linked to a change in the COL3A1 gene and can cause fragile arteries and hollow organs, creating a risk of spontaneous arterial, bowel, or uterine rupture.
How do classical EDS, Marfan syndrome, and Loeys-Dietz syndrome differ?
Classical EDS is marked by fragile, stretchy skin and wide, sunken scars. Marfan syndrome often involves enlargement of the aortic root, long fingers, chest or spine changes, and sometimes a displaced eye lens, while Loeys-Dietz syndrome can cause widespread twisting or enlargement of arteries plus features such as a split uvula. No single feature confirms any diagnosis.
Can a genetic test confirm hypermobile EDS?
There is no established gene test that confirms hEDS, so clinicians diagnose it using formal clinical criteria and by excluding other disorders. A connective-tissue panel may identify another condition, but a negative result does not rule out every disorder and a variant of uncertain significance is not a diagnosis.
Which family history findings suggest a vascular connective-tissue disorder?
Early or unexplained sudden death, aortic aneurysm, arterial dissection or rupture, bowel or other organ rupture, and similar events in close relatives should be discussed with a clinician. The absence of family history does not exclude these conditions because a new genetic change can occur.
Does everyone with hEDS need regular echocardiograms?
Not necessarily; the need for a baseline or repeat echocardiogram depends on your symptoms, aortic measurements, age, and family history. Mild aortic-root enlargement can occur in some people with hEDS, but that finding alone does not establish a vascular syndrome, so a cardiologist should guide follow-up.
What symptoms require emergency care if a vascular syndrome is possible?
Seek emergency evaluation for sudden severe chest, back, or abdominal pain; fainting, collapse, or new stroke-like symptoms; sudden severe shortness of breath; major unexplained bleeding; or acute abdominal pain or bleeding during pregnancy. Chronic musculoskeletal pain commonly associated with hEDS is not by itself a sign of a vascular emergency, but new or severe symptoms should not be ignored.

Related questions

What Kind of Doctor Diagnoses hEDS or HSD? How to Prepare Can Older Adults Be Diagnosed With hEDS If Less Flexible? Can You Have hEDS or HSD With a Borderline Beighton Score? Do hEDS and HSD Get Worse Over Time? Long-Term Outlook How Are hEDS and HSD Diagnosed in Children and Adolescents?
Show more
How Do I Get an hEDS or HSD Evaluation From a Doctor? How Common Are hEDS and Hypermobility Spectrum Disorder? Is Hypermobile EDS Hereditary? Family and Child Evaluation Is Joint Hypermobility Just Flexibility—or HSD or hEDS? Is Treatment Different for HSD vs. Hypermobile EDS? Can I Safely Do Beighton Score Tests for hEDS at Home? What Tests Rule Out Other Causes of Joint Hypermobility? What Causes hEDS and HSD If There Is No Genetic Test? What Exercises Are Safe for Hypermobile EDS and HSD? What Is the 5PQ for hEDS and How Is It Scored in Practice? What Should You Do for a Dislocated or Subluxing Joint? When Is Genetic Testing Recommended for Suspected EDS? Why Does Exercise Worsen hEDS or HSD Symptoms and Flares? Why Do Joints Sublux or Dislocate with hEDS or HSD?

Get notified when new evidence is published on hypermobility syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (26)
  1. 1

    Longitudinal echocardiography in pediatric patients with hypermobile Ehlers-Danlos syndrome.

    Lahey H, Shin H, Myers K, McBride KL

    American journal of medical genetics. Part A 2024; (194(12)):e63844 doi:10.1002/ajmg.a.63844.

    PMID: 39148461
  2. 2

    Multisystemic manifestations in a cohort of 75 classical Ehlers-Danlos syndrome patients: natural history and nosological perspectives.

    Ritelli M, Venturini M, Cinquina V, et al.

    Orphanet journal of rare diseases 2020; (15(1)):197 doi:10.1186/s13023-020-01470-0.

    PMID: 32736638
  3. 3

    Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome.

    Byers PH, Belmont J, Black J, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2017; (175(1)):40-47 doi:10.1002/ajmg.c.31553.

    PMID: 28306228
  4. 4

    Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome.

    Meester JAN, Verstraeten A, Schepers D, et al.

    Annals of cardiothoracic surgery 2017; (6(6)):582-594 doi:10.21037/acs.2017.11.03.

    PMID: 29270370
  5. 5

    Temporal Pattern Analysis of Ultrasound Surveillance Data in Vascular Connective Tissue Disorders.

    Walter C, Leinweber ME, Mlekusch I, et al.

    Diagnostics (Basel, Switzerland) 2024; (14(16)) doi:10.3390/diagnostics14161749.

    PMID: 39202237
  6. 6

    Hypermobile Ehlers-Danlos Syndrome: Diagnostic Challenges and the Role of Genetic Testing.

    Forghani I, See J, McGonigle WC

    Genes 2025; (16(5)) doi:10.3390/genes16050530.

    PMID: 40428350
  7. 7

    Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.

    Yew KS, Kamps-Schmitt KA, Borge R

    American family physician 2021; (103(8)):481-492.

    PMID: 33856167
  8. 8

    Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.

    Gensemer C, Burks R, Kautz S, et al.

    Developmental dynamics : an official publication of the American Association of Anatomists 2021; (250(3)):318-344 doi:10.1002/dvdy.220.

    PMID: 32629534
  9. 9

    Extracutaneous features and complications of the Ehlers-Danlos syndromes: A systematic review.

    Doolan BJ, Lavallee ME, Hausser I, et al.

    Frontiers in medicine 2023; (10()):1053466 doi:10.3389/fmed.2023.1053466.

    PMID: 36756177
  10. 10

    Hypermobile Ehlers-Danlos syndrome: A review and a critical appraisal of published genetic research to date.

    Scicluna K, Formosa MM, Farrugia R, Borg I

    Clinical genetics 2022; (101(1)):20-31 doi:10.1111/cge.14026.

    PMID: 34219226
  11. 11

    Hypermobile Ehlers Danlos for the Primary Care Provider.

    White L, Procknow SS

    Missouri medicine 2024; (121(4)):289-296.

    PMID: 39575079
  12. 12

    Assessment of gait mechanics and muscle strength in hypermobile Ehlers Danlos Syndrome.

    Ball LN, Jacobs MV, McLouth CJ, et al.

    Clinical biomechanics (Bristol, Avon) 2024; (113()):106210 doi:10.1016/j.clinbiomech.2024.106210.

    PMID: 38412743
  13. 13

    Clinical and molecular characteristics of 168 probands and 65 relatives with a clinical presentation of classical Ehlers-Danlos syndrome.

    Colman M, Syx D, De Wandele I, et al.

    Human mutation 2021; (42(10)):1294-1306 doi:10.1002/humu.24258.

    PMID: 34265140
  14. 14

    Application of the 2017 criteria for vascular Ehlers-Danlos syndrome in 50 patients ascertained according to the Villefranche nosology.

    Ritelli M, Rovati C, Venturini M, et al.

    Clinical genetics 2020; (97(2)):287-295 doi:10.1111/cge.13653.

    PMID: 31600821
  15. 15

    Tissue vulnerability revealed by ultrastructural skin analysis as a surrogate for arterial integrity in two cases of vascular Ehlers-Danlos syndrome.

    Bhandari A, Keene DR, Tufa SF, et al.

    Journal of vascular surgery cases and innovative techniques 2026; (12(5)):102334 doi:10.1016/j.jvscit.2026.102334.

    PMID: 42502438
  16. 16

    Cellular and Molecular Mechanisms in the Pathogenesis of Classical, Vascular, and Hypermobile Ehlers‒Danlos Syndromes.

    Chiarelli N, Ritelli M, Zoppi N, Colombi M

    Genes 2019; (10(8)) doi:10.3390/genes10080609.

    PMID: 31409039
  17. 17

    Orthopaedic Conditions Associated with Aneurysms.

    Marrache M, Byers PH, Sponseller PD

    JBJS reviews 2020; (8(6)):e0122 doi:10.2106/JBJS.RVW.19.00122.

    PMID: 33006458
  18. 18

    Cardiovascular Manifestations and Complications of Loeys-Dietz Syndrome: CT and MR Imaging Findings.

    Loughborough WW, Minhas KS, Rodrigues JCL, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2018; (38(1)):275-286 doi:10.1148/rg.2018170120.

    PMID: 29320330
  19. 19

    Bone Fragility in Hereditary Connective Tissue Disorders: A Systematic Review and Meta-Analysis.

    Charoenngam N, Rittiphairoj T, Ponvilawan B, et al.

    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2023; (29(7)):589-600 doi:10.1016/j.eprac.2023.02.003.

    PMID: 36804968
  20. 20

    Bone involvement in adult patients affected with Ehlers-Danlos syndrome.

    Eller-Vainicher C, Bassotti A, Imeraj A, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2016; (27(8)):2525-31 doi:10.1007/s00198-016-3562-2.

    PMID: 27084695
  21. 21

    Utilization of echocardiography in Ehlers-Danlos syndrome.

    Rauser-Foltz KK, Starr LJ, Yetman AT

    Congenital heart disease 2019; (14(5)):864-867 doi:10.1111/chd.12824.

    PMID: 31328377
  22. 22

    A Novel Mutation of TGFB2 Gene Responsible of Loeys-Dietz 4 Syndrome.

    Di Zazzo E, Buonagura AT, Palladino V, et al.

    International medical case reports journal 2025; (18()):1353-1357 doi:10.2147/IMCRJ.S544549.

    PMID: 41170304
  23. 23

    Manifestations and Medicolegal Significance of Loeys-Dietz Syndrome.

    Byard RW

    Journal of forensic sciences 2017; (62(6)):1512-1515 doi:10.1111/1556-4029.13466.

    PMID: 28230898
  24. 24

    Genetic complexity of diagnostically unresolved Ehlers-Danlos syndrome.

    Vandersteen AM, Weerakkody RA, Parry DA, et al.

    Journal of medical genetics 2024; (61(3)):232-238 doi:10.1136/jmg-2023-109329.

    PMID: 37813462
  25. 25

    Genetic factors and management strategies in aortic health: a literature review of inherited aortopathy.

    Elendu C, Nzeako TR, Nwachukwu NO, et al.

    Annals of medicine and surgery (2012) 2025; (87(2)):598-615 doi:10.1097/MS9.0000000000002969.

    PMID: 40110250
  26. 26

    Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/ehlers-danlos syndrome hypermobility type compared to other heritable connective tissue disorders.

    Colombi M, Dordoni C, Chiarelli N, Ritelli M

    American journal of medical genetics. Part C, Seminars in medical genetics 2015; (169C(1)):6-22 doi:10.1002/ajmg.c.31429.

    PMID: 25821090

This comparison is for informational purposes only and does not constitute medical advice or a diagnosis. A clinical geneticist, cardiologist, or other qualified clinician should interpret your symptoms, family history, imaging, and genetic test results.